These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 355144)
1. Serotyping in epidemiological tracing of nosocomially acquired Proteus mirabilis in a geriatric ward. Larsson P; Andersson HE; Norlén B Infection; 1978; 6(3):105-10. PubMed ID: 355144 [TBL] [Abstract][Full Text] [Related]
2. Serious nosocomial infection caused by Morganella morganii and Proteus mirabilis in a cardiac surgery unit. Williams EW; Hawkey PM; Penner JL; Senior BW; Barton LJ J Clin Microbiol; 1983 Jul; 18(1):5-9. PubMed ID: 6350354 [TBL] [Abstract][Full Text] [Related]
3. [Detection of hospital strains of Proteus mirabilis by the methods of proticine and bacteriophage typing]. Zawieja M Med Dosw Mikrobiol; 1988; 40(4):213-8. PubMed ID: 3073282 [No Abstract] [Full Text] [Related]
4. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study. Sekaninová G; Kolárová M Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720 [TBL] [Abstract][Full Text] [Related]
5. A nosocomial outbreak of infections due to multiply resistant Proteus mirabilis: role of intestinal colonization as a major reservoir. Chow AW; Taylor PR; Yoshikawa TT; Guze LB J Infect Dis; 1979 Jun; 139(6):621-7. PubMed ID: 376760 [TBL] [Abstract][Full Text] [Related]
6. Immunochemical characterization of the O antigens of two Proteus strains, O8-related antigen of Proteus mirabilis 12 B-r and O2-related antigen of Proteus genomospecies 5/6 12 B-k, infecting a hospitalized patient in Poland. Drzewiecka D; Shashkov AS; Arbatsky NP; Knirel YA Microbiology (Reading); 2016 May; 162(5):789-797. PubMed ID: 26959528 [TBL] [Abstract][Full Text] [Related]
7. The use of the Dienes test in the epidemiology of proteus urinary tract infections in patients with spinal cord disease. Herruzo-Cabrera R; Garcia-Caballero J; Garcia-Reneses J; Garcia-Caballero F; Rey-Calero J J Hosp Infect; 1984 Mar; 5(1):92-5. PubMed ID: 6202754 [TBL] [Abstract][Full Text] [Related]
8. Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase. Nagano N; Shibata N; Saitou Y; Nagano Y; Arakawa Y J Clin Microbiol; 2003 Dec; 41(12):5530-6. PubMed ID: 14662935 [TBL] [Abstract][Full Text] [Related]
9. Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis. Penner JL; Hennessy JN J Clin Microbiol; 1980 Sep; 12(3):304-9. PubMed ID: 7012166 [TBL] [Abstract][Full Text] [Related]
10. Structural and serological studies of the O-polysaccharide of strains from a newly created Proteus O78 serogroup prevalent in Polish patients. Drzewiecka D; Arbatsky NP; Staczek P; Shashkov AS; Knirel YA; Sidorczyk Z FEMS Immunol Med Microbiol; 2010 Mar; 58(2):269-76. PubMed ID: 20002745 [TBL] [Abstract][Full Text] [Related]
11. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing]. Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández Crehuet M; Cueto Espinar A; Piédrola Angulo G Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246 [No Abstract] [Full Text] [Related]
12. The Dienes effect as an epidemiological tool in a paraplegic unit. Herruzo-Cabrera R; Garcia-Caballero J; Medrano-Albero MJ; Villar-Alvarez F; Moreno-Moreno JJ; Rey-Calero J Eur J Epidemiol; 1988 Jun; 4(2):212-5. PubMed ID: 3042449 [TBL] [Abstract][Full Text] [Related]
13. Infection caused by Proteus mirabilis strains with transferrable gentamicin-resistance factors. Datta N Lancet; 1975 Jun; 1(7921):1355-7. PubMed ID: 48945 [TBL] [Abstract][Full Text] [Related]
14. Serotyping and the Dienes reaction on Proteus mirabilis from hospital infections. De Louvois J J Clin Pathol; 1969 May; 22(3):263-8. PubMed ID: 4891480 [TBL] [Abstract][Full Text] [Related]
15. Clinical features of Proteus mirabilis pneumonia. Okimoto N; Hayashi T; Ishiga M; Nanba F; Kishimoto M; Yagi S; Kurihara T; Asaoka N; Tamada S J Infect Chemother; 2010 Oct; 16(5):364-6. PubMed ID: 20502932 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of Proteus mirabilis by bacteriophage typing and the Dienes reaction. Hickman FW; Farmer JJ J Clin Microbiol; 1976 Mar; 3(3):350-8. PubMed ID: 773962 [TBL] [Abstract][Full Text] [Related]
17. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup. Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848 [TBL] [Abstract][Full Text] [Related]
18. [Investigations made to test the demarcation line method (DLM) after Dienes for its suitability in the epidemiology of Proteus mirabilis (author's transl)]. Sohnius I; Lenk V Zentralbl Bakteriol Orig B; 1977; 164(4):384-9. PubMed ID: 329623 [TBL] [Abstract][Full Text] [Related]
19. [Epidemiological application of the Cradock-Watson system for Proteus mirabilis. Comparative study with another system of bacteriocin typing]. Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Rubio Peiró R; Piédrola Angulo G Rev Latinoam Microbiol; 1985; 27(2):77-81. PubMed ID: 3906814 [No Abstract] [Full Text] [Related]
20. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures. Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]